Literature DB >> 12744713

Marijuana as doping in sports.

Daniel R Campos1, Mauricio Yonamine, Regina L de Moraes Moreau.   

Abstract

A high incidence of positive cases for cannabinoids, in analyses for doping control in sports, has been observed since the International Olympic Committee (IOC) included them in the 1989 list of prohibited drugs under the title of classes of prohibited substances in certain circumstances. Where the rules of sports federations so provide, tests are conducted for marijuana, hashish or any other cannabis product exposure by means of urinalysis of 11-nor-delta-9-tetrahydrocannabinol-9-carboxylic acid (carboxy-THC) the main metabolite of delta-9-tetrahydrocannabinol (THC). Concentrations >15 ng/mL (cut-off value) in confirmatory analytical procedures are considered doping. Cannabis is an illicit drug in several countries and has received much attention in the media for its potential therapeutic uses and the efforts to legalise its use. Studies have demonstrated that the use of cannabinoids can reduce anxiety, but it does not have ergogenic potential in sports activities. An increase in heart rate and blood pressure, decline of cardiac output and reduced psychomotor activity are some of the pharmacological effects of THC that will determine a decrease in athletic performance. An ergolytic activity of cannabis products has been observed in athletes of several different sport categories. In Brazil, analyses for doping control in sports, performed in our laboratories, have detected positive cases for carboxy-THC in urine samples of soccer, volleyball, cycling and other athletes. It is our intention to discuss in this article some points that may discourage individuals from using cannabis products during sports activities, even in the so-called permitted circumstances defined by the IOC and some sports federations.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12744713     DOI: 10.2165/00007256-200333060-00001

Source DB:  PubMed          Journal:  Sports Med        ISSN: 0112-1642            Impact factor:   11.136


  12 in total

Review 1.  Drug use and abuse in sport.

Authors:  M Verroken
Journal:  Baillieres Best Pract Res Clin Endocrinol Metab       Date:  2000-03

Review 2.  Pharmacology of cannabinoid CB1 and CB2 receptors.

Authors:  R G Pertwee
Journal:  Pharmacol Ther       Date:  1997       Impact factor: 12.310

3.  Detection times of marijuana metabolites in urine by immunoassay and GC-MS.

Authors:  M A Huestis; J M Mitchell; E J Cone
Journal:  J Anal Toxicol       Date:  1995-10       Impact factor: 3.367

4.  Identification of 9 -tetrahydrocannabinol and metabolites in man.

Authors:  M E Wall; D R Brine; C G Pitt; M Perez-Reyes
Journal:  J Am Chem Soc       Date:  1972-11-29       Impact factor: 15.419

5.  Urinary excretion profiles of 11-nor-9-carboxy-delta 9-tetrahydrocannabinol in humans after single smoked doses of marijuana.

Authors:  M A Huestis; J M Mitchell; E J Cone
Journal:  J Anal Toxicol       Date:  1996-10       Impact factor: 3.367

Review 6.  Cannabis: pharmacology and toxicology in animals and humans.

Authors:  I B Adams; B R Martin
Journal:  Addiction       Date:  1996-11       Impact factor: 6.526

Review 7.  Banned drugs in sport. Does the International Olympic Committee (IOC) list need updating?

Authors:  D R Mottram
Journal:  Sports Med       Date:  1999-01       Impact factor: 11.136

Review 8.  The endocannabinoid nervous system: unique opportunities for therapeutic intervention.

Authors:  A C Porter; C C Felder
Journal:  Pharmacol Ther       Date:  2001-04       Impact factor: 12.310

Review 9.  Ergolytic drugs in medicine and sports.

Authors:  E R Eichner
Journal:  Am J Med       Date:  1993-02       Impact factor: 4.965

10.  Metabolism of tetrahydrocannabinol in frequent and infrequent marijuana users.

Authors:  P Kelly; R T Jones
Journal:  J Anal Toxicol       Date:  1992 Jul-Aug       Impact factor: 3.367

View more
  7 in total

1.  Doping Attitudes and Covariates of Potential Doping Behaviour in High-Level Team-Sport Athletes; Gender Specific Analysis.

Authors:  Damir Sekulic; Enver Tahiraj; Milan Zvan; Natasa Zenic; Ognjen Uljevic; Blaz Lesnik
Journal:  J Sports Sci Med       Date:  2016-12-01       Impact factor: 2.988

2.  A strategy to reduce illicit drug use is effective in elite Australian football.

Authors:  Peter R Harcourt; Harry Unglik; Jill L Cook
Journal:  Br J Sports Med       Date:  2012-08-14       Impact factor: 13.800

3.  The Olympics and harm reduction?

Authors:  Bengt Kayser; Barbara Broers
Journal:  Harm Reduct J       Date:  2012-07-13

Review 4.  Marijuana: current concepts(†).

Authors:  Donald E Greydanus; Elizabeth K Hawver; Megan M Greydanus; Joav Merrick
Journal:  Front Public Health       Date:  2013-10-10

Review 5.  Cannabis and the Health and Performance of the Elite Athlete.

Authors:  Mark A Ware; Dennis Jensen; Amy Barrette; Alan Vernec; Wayne Derman
Journal:  Clin J Sport Med       Date:  2018-09       Impact factor: 3.638

Review 6.  Cannabis and Athletic Performance.

Authors:  Jamie F Burr; Christian P Cheung; Andreas M Kasper; Scott H Gillham; Graeme L Close
Journal:  Sports Med       Date:  2021-09-13       Impact factor: 11.136

7.  Current anti-doping policy: a critical appraisal.

Authors:  Bengt Kayser; Alexandre Mauron; Andy Miah
Journal:  BMC Med Ethics       Date:  2007-03-29       Impact factor: 2.652

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.